(Q53113911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Sabrina Boodhan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Mark Holdsworth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Paula D Robinson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Richard Hain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Carol Portwine

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Erin O'Shaughnessy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Lillian Sung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Pediatric Oncology Group of Ontario

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

19 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

published in

Pediatric Blood & Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1073-1082

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23512831%20AND%20SRC:MED&resulttype=core&format=json

Symptom assessment in children receiving cancer therapy: the parents' perspective

26 February 2020

cites work

1 reference

Aggressive treatment of non-metastatic osteosarcoma improves health-related quality of life in children and adolescents

21 January 2018

1 reference

Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients.

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

21 January 2018

1 reference

Antiemetics: American Society of Clinical Oncology clinical practice guideline update

21 January 2018

1 reference

Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

Acute and delayed nausea and emesis control in pediatric oncology patients

21 January 2018

1 reference

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

21 January 2018

1 reference

Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.

21 January 2018

1 reference

Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability

21 January 2018

1 reference

Aprepitant Use in Children, Adolescents, and Young Adults for the Control of Chemotherapy-Induced Nausea and Vomiting (CINV)

21 January 2018

1 reference

Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone

21 January 2018

1 reference

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

21 January 2018

1 reference

Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescents

21 January 2018

1 reference

Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis

21 January 2018

1 reference

Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia

21 January 2018

1 reference

Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy

21 January 2018

1 reference

Nabilone: an alternative antiemetic for cancer chemotherapy

21 January 2018

1 reference

5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment

21 January 2018

1 reference

A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer

21 January 2018

1 reference

Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based chemotherapy in pediatric outpatients with acute lymphoblastic leukemia

21 January 2018

1 reference

Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children

21 January 2018

1 reference